Physical Activity, Air Pollution, and High Blood Pressure
NCT ID: NCT05092672
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2021-11-15
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Joint Effect of Air Pollution and Exercise on Cognitive Function
NCT04830059
Cycling, Air Pollution and Health
NCT01708356
Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly
NCT05207501
Diet and Exercise on Ambulatory Blood Pressure
NCT05274971
Intensity Training and Cardiovascular Health in Colombian Adults
NCT02738385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High traffic-related air pollution first
Participants will exercise in an environment with high levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with low levels of traffic-related air pollution.
Exercise
Participants will engage in moderate-intensity (40-59% HRR) exercise for 30 min
Low traffic-related air pollution
Participants will exercise in an environment with low levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with high levels of traffic-related air pollution.
Exercise
Participants will engage in moderate-intensity (40-59% HRR) exercise for 30 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Participants will engage in moderate-intensity (40-59% HRR) exercise for 30 min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Previously diagnosed with elevated blood pressure or hypertension by a physician
Exclusion Criteria
2. Lives with an individual who currently smokes cigarettes, e-cigarettes (i.e., vaping), or cannabis
3. Hormone replacement therapy use
4. Currently on beta-blocker or angiotensin receptor blocker (ARB) therapy
5. Currently using over the counter drugs or supplements that may alter cardiovascular measures (as per the principal investigator's discretion)
6. Prior diagnosis of any other existing cardiovascular or pulmonary diseases and/or conditions (other than hypertension)
7. Musculoskeletal injury or lower limb limitation preventing safe engagement in moderate-intensity exercise
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Koehle
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Koehle, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H21-01487
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.